### Maven Clinic Secures $125 Million in Funding, Reaching $1.7 Billion Valuation

Maven Clinic, a pioneering health-care startup focused on women's and family health, announced the successful closure of a $125 million funding round, propelling the company to a valuation of $1.7 billion. Maven aims to offer comprehensive virtual care that spans the entire reproductive lifecycle, providing support for everything from family planning to menopause.

Founded in 2014 by CEO Kate Ryder, Maven Clinic was born from Ryder observing her friends struggle to obtain adequate support while building their families. Fast forward ten years, Maven now covers around 17 million lives through partnerships with major companies such as Amazon, Microsoft, and AT&T. This recent funding round increases Maven’s total capital raised to over $425 million, which will be used to enhance its fertility benefits, expand its digital platform, and leverage real-time data for more proactive healthcare.

Maven is a three-time member of the CNBC Disruptor 50 list and holds the distinction of being the first U.S. startup dedicated to women's and family health to achieve "unicorn" status. Among its investors are high-profile venture firms like General Catalyst, Sequoia, and Oak HC/FT, as well as celebrities such as Oprah Winfrey, Mindy Kaling, and Reese Witherspoon. Ryder mentioned that while the company is currently concentrating on advancing its product roadmap, there are plans to eventually go public.

The recent overturning of Roe v. Wade by the U.S. Supreme Court in June 2022 thrust Maven Clinic into the spotlight as employers turned to it for navigating gaps in reproductive care. Ryder decried the ruling as a "devastating step back for healthcare in the United States" and expressed Maven’s commitment to helping clients facilitate travel reimbursements for healthcare across state lines. Following the ruling, the company experienced a 67% month-over-month surge in interest for travel and health care benefits for pregnant individuals.

In 2022, a Deloitte report noted a 5% increase in venture investments in women's health companies, contrasting with a 27% decline in venture funding for the broader health tech market during the same period. Maven itself had closed a $90 million funding round in November of that year. Ryder emphasized the critical importance of data in shaping future health policies, particularly as restrictive care access continues to result in preventable deaths.

"The question is, to be honest, when? And how many more people need to needlessly suffer in the meantime?" Ryder said, highlighting the urgent need for policy change driven by increased funding and robust data.

With this new injection of capital, Maven Clinic is poised to continue its innovative journey in transforming women's and family health, striving for smarter and more inclusive healthcare solutions.